Alice Goodman


4638 e. berneil




Adjuvant therapy fails in locally advanced kidney Ca

April 06, 2015

Two angiogenesis inhibitors that are widely used in metastatic renal cell carcinoma did not improve survival compared with placebo when used as adjuvant treatment, a new study found.

Protein may predict resistance to prostate cancer Tx

April 23, 2014

Researchers have come up with a potential blood-based biomarker that can identify men with castration-resistant prostate cancer who are not likely to respond to enzalutamide (XTANDI).

Growth factor inhibition shows promise in bladder Ca

April 23, 2014

Preliminary studies suggest that inhibition of fibroblast growth factor receptors (FGFR) 1, 2, 3, and 4 may be a promising approach for the treatment of bladder cancers and other cancers that harbor FGFR alterations.

Bladder cancer study identifies therapeutic targets

March 25, 2014

A comprehensive molecular characterization of muscle-invasive urothelial bladder carcinoma suggests multiple opportunities for therapeutic intervention.